interleukin-13 Roche Discussing Phase III Study with FDA for Personalized Asthma Drug Lebrikizumab Premium By Turna Ray Breaking News People in the News at Danaher, QuidelOrtho, Myriad Genetics, Hologic, Pacific Biosciences, More New Products Posted to GenomeWeb: Qiagen, Parse Biosciences, Bio-Techne T2 Biosystems Receives Delisting Notice From Nasdaq In Brief This Week: Inocras, Sysmex Inostics, Danaher, Abbott, Genesupport, GeninCode, More Roche Receives CE Mark for Updated High-Throughput Cobas Platform
